feed,title,long_url,short_url
Benzinga,"EMA accepts regulatory submission for avalglucosidase alfa, a potentially new standard of care enzyme replacement therapy for Pompe disease",https://www.benzinga.com/pressreleases/20/10/g17749698/ema-accepts-regulatory-submission-for-avalglucosidase-alfa-a-potentially-new-standard-of-care-enzy,https://j.mp/3ikXi4j
